NCT03076242View on ClinicalTrials.gov

Genetic Evaluation of Men (GEM)

TerminatedOBSERVATIONAL
Enrollment

595

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

January 15, 2019

Study Completion Date

May 16, 2019

Conditions
Prostate Cancer
Interventions
OTHER

GEM Registry

Men with a personal history of PCA; Unaffected males who are at higher risk for prostate cancer

Trial Locations (3)

19001

Abington Memorial Hospital, Abington

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

Sponsors

Collaborators (1)

Myriad Genetics, Inc.
All Listed Sponsors
collaborator

Myriad Genetics, Inc.

INDUSTRY

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT03076242 - Genetic Evaluation of Men (GEM) | Biotech Hunter | Biotech Hunter